Skip to content
PubMed This is a summary of 16 peer-reviewed journal articles Updated
Neurology

Genetics and Inheritance of MDS

At a Glance

Myoclonus-dystonia syndrome is often linked to an SGCE mutation. Because the maternal copy is usually silenced, inheriting the mutation from a father is much more likely to cause symptoms than inheriting it from a mother, making genetic counseling important.

Genetic testing has transformed our understanding of Myoclonus-Dystonia Syndrome (MDS), moving it from a “mysterious” set of symptoms to a condition with an underlying biological cause. In about 30% to 50% of people with classic MDS, a mutation is found in the SGCE gene [1]. Understanding how this gene is passed down is essential, as it follows a unique and sometimes confusing rule called maternal imprinting.

The SGCE Gene: The Primary Blueprint

The SGCE gene provides instructions for making a protein called epsilon-sarcoglycan [2]. While scientists are still researching exactly what this protein does, it is found throughout the brain and is believed to help stabilize the connections between nerve cells (synapses) and regulate how calcium moves within those cells [3][4].

When there is a “typo” or mutation in this gene, the protein doesn’t work correctly, leading to the characteristic jerks and postures of MDS. While SGCE is the most common cause, researchers have identified other rare genes that can cause similar symptoms, such as KCTD17 and KCNN2, though evidence for these causing classic MDS is still emerging [5][6].

Maternal Imprinting: The “Silencing” Rule

Most of our genes come in pairs—one from our mother and one from our father—and both copies are usually active. However, SGCE is different because it is subject to maternal imprinting [7]. This means the copy of the gene inherited from the mother is naturally, though not invariably, “turned off” or silenced in the brain [8].

This leads to a specific pattern of inheritance:

  • Inherited from the Father: If a child inherits the mutated gene from their father, the “active” copy is broken, and they have a very high chance (cohort estimates suggest around 95%) of developing symptoms [9][10].
  • Inherited from the Mother: If a child inherits the mutated gene from their mother, it is usually silenced. These children often carry the mutation but do not show symptoms, though occasionally symptoms can still appear [9][11].
  • De Novo Mutations: Sometimes, the mutation is not inherited at all but happens for the first time in the child (de novo). In these cases, neither parent carries the gene, though residual uncertainty like parental mosaicism (a mix of healthy and mutated cells) is possible [11][12].

Why Families Look Different: Penetrance and Expressivity

Even within the same family, MDS can look very different from person to person. This is due to two medical concepts:

  1. Incomplete Penetrance: Not everyone with the mutation will show symptoms. This is most common when the gene is inherited from the mother, but occasionally even a paternal inheritance results in no visible symptoms [9].
  2. Variable Expressivity: Relatives with the exact same mutation may have vastly different experiences. One person might have severe, life-altering jerks, while their sibling might only have a mild “writer’s cramp” or struggle with anxiety [13][14].

The Importance of Genetic Testing and Counseling

Because the inheritance pattern is so complex, professional genetic counseling is highly recommended for any family dealing with MDS.

  • Confirming the Diagnosis: Genetic testing can support the diagnosis and help doctors rule out other conditions, though a negative result does not rule out clinically diagnosed MDS, and a Variant of Uncertain Significance (VUS) should not be treated as a definitive cause [1].
  • Family Planning: A counselor can explain the specific risks for future children. For example, any person carrying the variant has a 50% chance of passing the gene to his or her children, but the chance of those children expressing symptoms depends heavily on whether it was passed by a father or a mother [9].
  • Testing Relatives: Identifying carriers in the family can be important for their own family planning. Keep in mind that anxiety or OCD in a relative alone does not prove that person carries the MDS variant [13][15].

Testing should often include both sequencing (reading the gene) and deletion/duplication analysis (checking for missing chunks of the gene) to ensure no mutations are missed [11][16].

Common questions in this guide

What gene most often causes myoclonus-dystonia syndrome?
A change in the SGCE gene is the most common known genetic cause and is found in about 30% to 50% of people with classic MDS. Other rare genes, including KCTD17 and KCNN2, may cause similar symptoms, but evidence for their role is still emerging.
How does maternal imprinting affect MDS inheritance?
The SGCE copy inherited from the mother is usually switched off in the brain, while the copy inherited from the father is generally active. A child who inherits an SGCE variant from the father is therefore much more likely to develop symptoms, although symptoms can occasionally occur after maternal inheritance.
Can I have MDS even if my genetic test is negative?
Yes. A negative genetic result does not rule out clinically diagnosed MDS, because a test may not detect every genetic cause or type of change. Testing may include both gene sequencing and deletion or duplication analysis, and a variant of uncertain significance is not proof that the variant caused the condition.
What is the chance of passing an SGCE variant to my children?
A person who carries an SGCE variant has a 50% chance of passing it to each child. The child's chance of developing symptoms depends strongly on whether the variant was inherited from the father or mother, although the pattern is not absolute.
What does a de novo mutation mean in MDS?
A de novo mutation is a genetic change that appears for the first time in a child, so neither parent carries it in the tested cells. Rare parental mosaicism, in which only some cells carry the change, can leave a small amount of uncertainty about recurrence in future children.
Can someone carry an SGCE variant without having visible jerks?
Yes. People who inherit the variant from their mother often carry it without obvious movement symptoms, and even relatives with the same variant can have different experiences. Anxiety or obsessive-compulsive symptoms alone do not prove that someone carries an MDS-related variant, so genetic counseling and appropriate testing are important.

Get notified when new evidence is published on Myoclonus-dystonia syndrome.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (16)
  1. 1

    Delineating the motor phenotype of SGCE-myoclonus dystonia syndrome.

    Vanegas MI, Marcé-Grau A, Martí-Sánchez L, et al.

    Parkinsonism & related disorders 2020; (80()):165-174 doi:10.1016/j.parkreldis.2020.09.023.

    PMID: 33022436
  2. 2

    Twenty years on: Myoclonus-dystonia and ε-sarcoglycan - neurodevelopment, channel, and signaling dysfunction.

    Menozzi E, Balint B, Latorre A, et al.

    Movement disorders : official journal of the Movement Disorder Society 2019; (34(11)):1588-1601 doi:10.1002/mds.27822.

    PMID: 31449710
  3. 3

    ε-Sarcoglycan: Unraveling the Myoclonus-Dystonia Gene.

    Cazurro-Gutiérrez A, Marcé-Grau A, Correa-Vela M, et al.

    Molecular neurobiology 2021; (58(8)):3938-3952 doi:10.1007/s12035-021-02391-0.

    PMID: 33886091
  4. 4

    Mutation in ε-Sarcoglycan Induces a Myoclonus-Dystonia Syndrome-Like Movement Disorder in Mice.

    Li J, Liu Y, Li Q, et al.

    Neuroscience bulletin 2021; (37(3)):311-322 doi:10.1007/s12264-020-00612-5.

    PMID: 33355901
  5. 5

    Beyond SGCE: expanding the clinical and molecular spectrum of KCTD17- and KCNN2-related myoclonus-dystonia.

    Krygier M, Sitek EJ, Chylińska M, et al.

    Frontiers in neurology 2026; (17()):1728361 doi:10.3389/fneur.2026.1728361.

    PMID: 41982418
  6. 6

    KCNN2 mutation in autosomal-dominant tremulous myoclonus-dystonia.

    Balint B, Guerreiro R, Carmona S, et al.

    European journal of neurology 2020; (27(8)):1471-1477 doi:10.1111/ene.14228.

    PMID: 32212350
  7. 7

    Faithful SGCE imprinting in iPSC-derived cortical neurons: an endogenous cellular model of myoclonus-dystonia.

    Grütz K, Seibler P, Weissbach A, et al.

    Scientific reports 2017; (7()):41156 doi:10.1038/srep41156.

    PMID: 28155872
  8. 8

    A Japanese family with dystonia due to a pathogenic variant in SGCE.

    Morikawa T, Miura S, Fan L, et al.

    Human genome variation 2022; (9(1)):29 doi:10.1038/s41439-022-00207-8.

    PMID: 35995778
  9. 9

    A Genetics Pearl for Counseling Patients with Epsilon-Sarcoglycan Myoclonus-Dystonia.

    Higinbotham AS, DeBrosse SD, Kilbane CW

    Tremor and other hyperkinetic movements (New York, N.Y.) 2023; (13()):24 doi:10.5334/tohm.783.

    PMID: 37637852
  10. 10

    From SGCE gene to symptoms: decoding myoclonus-dystonia.

    Peng X, Lei X, Yang L, He D

    Acta neurologica Belgica 2025; doi:10.1007/s13760-025-02935-4.

    PMID: 41331696
  11. 11

    [Clinical and genetic analysis of childhood-onset myoclonus dystonia syndrome caused by SGCE variants].

    Tian XJ, Ding CH, Zhang YH, et al.

    Zhonghua er ke za zhi = Chinese journal of pediatrics 2020; (58(2)):123-128 doi:10.3760/cma.j.issn.0578-1310.2020.02.011.

    PMID: 32102149
  12. 12

    Novel SGCE Mutation in a Patient With Myoclonus-Dystonia: A Case Report.

    Klinman E, Gooch C, Perlmutter JS, et al.

    Neurology. Genetics 2024; (10(2)):e200128 doi:10.1212/NXG.0000000000200128.

    PMID: 38486676
  13. 13

    Clinical phenotype heterogeneity in a family with ε-sarcoglycan gene mutation.

    Kaczyńska J, Jamrozik Z, Szubiga M, et al.

    Neurologia i neurochirurgia polska 2020; (54(1)):33-38 doi:10.5603/PJNNS.a2020.0005.

    PMID: 31956970
  14. 14

    A Novel SGCE Nonsense Variant Associated With Marked Intrafamilial Variability in a Turkish Family With Myoclonus-Dystonia.

    Gultekin M, Prakash N, Ganos C, et al.

    Movement disorders clinical practice 2019; (6(6)):479-482 doi:10.1002/mdc3.12805.

    PMID: 31392249
  15. 15

    Population Prevalence of Deleterious SGCE Variants.

    LeDoux MS

    Tremor and other hyperkinetic movements (New York, N.Y.) 2020; (10()):50 doi:10.5334/tohm.567.

    PMID: 33200041
  16. 16

    Progression of neuropsychiatric and cognitive features due to exons 2 to 5 deletion in the epsilon-sarcoglycan gene: a case report.

    Multani N, Moro E, Lang A, et al.

    Neurocase 2016; (22(2)):215-9 doi:10.1080/13554794.2015.1120312.

    PMID: 26652670

This page explains SGCE inheritance and genetic testing in MDS for informational purposes only and does not constitute medical advice. A neurologist or genetic counselor can interpret your results and discuss personal risks and family planning.